Table 1.
Assay | Calibration range | Sensitivity | Between-day precision %CV | Clinical applications* |
---|---|---|---|---|
AFP | 0.2–300 ng/mL | 0.24 ng/mL | 4.5–7.5 | Diagnose neural tube defects and development abnormalities |
HCS | 2–50 μmol/L | 0.5 μmol/L | 2.9–8.6 | Diagnose: pediatric atherosclerosis, cardiovascular disease, schizophrenia |
Insulin | 2–300 μIU/mL | 2 μIU/mL | 3.6–7.6 | Management of insulin-dependent diabetes |
IGF-1 | 25–1600 ng/mL | 20 ng/mL | 2.9–4.9 | Diagnose growth disorder (GH deficiency or excess); assess nutritional status |
IGFBP-3 | 0.5–16 μg/mL | 0.1 μg/mL | 3.4–7.7 | Differential diagnosis of growth disorders |
C-peptide | 0.5–7 ng/mL | 0.3 ng/mL | 2.8–9.1 | A marker for insulin production |
IgE | 1–2000 IU/mL | 1 IU/mL | 5.1–9.6 | Indicates allergic reaction |
i-PTH | 1–2500 pg/mL | 1 pg/mL | 6.1–8.5 | Help identify hyperparathyroidism or to find the cause of abnormal calcium levels |
Tietz, Textbook of Clinical Chemistry and Molecular Diagnostics, 4th edition 2006, eds. Burtis, Ashwood, Bruns. Publishers: Elsevier Saunders.